Smartleaf Asset Management’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.58K Hold
122
﹤0.01% 2795
2026
Q1
$2.24K Sell
122
-1,279
-91% -$24.4K ﹤0.01% 2931
2025
Q4
$32.5K Buy
1,401
+43
+3% +$1.11K ﹤0.01% 1772
2025
Q3
$36.5K Buy
1,358
+38
+3% +$906 ﹤0.01% 1550
2025
Q2
$22.3K Buy
1,320
+423
+47% +$7.46K ﹤0.01% 1503
2025
Q1
$16K Buy
897
+482
+116% +$9.67K ﹤0.01% 1723
2024
Q4
$9.99K Buy
415
+132
+47% +$3.77K ﹤0.01% 1985
2024
Q3
$10.5K Buy
283
+73
+35% +$2.72K ﹤0.01% 1720
2024
Q2
$9.82K Buy
+210
New +$9.2K ﹤0.01% 1420

Other funds holding STAA

Smartleaf Asset Management's STAA Position: Q2 2026 in Review

Smartleaf Asset Management held its STAAR Surgical (STAA) position steady in Q2 2026 at 122 shares worth $3.58K. The position accounts for ﹤0.01% of the portfolio, ranked #2795.

Smartleaf Asset Management first reported a position in STAA in Q2 2024 and has held it in 9 quarters since. The position peaked at $36.5K in Q3 2025. 200 funds tracked by Wall St. Rank hold STAA as of Q2 2026.

  • Smartleaf Asset Management held 122 shares of STAAR Surgical worth $3.58K as of Q2 2026.
  • Smartleaf Asset Management left its STAAR Surgical share count unchanged in Q2 2026.
  • STAAR Surgical made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #2795 holding.
  • Smartleaf Asset Management first reported a position in STAAR Surgical in Q2 2024 and has held it in 9 quarters since.
  • Smartleaf Asset Management's STAAR Surgical position peaked at $36.5K in Q3 2025.
  • 200 funds tracked by Wall St. Rank held STAAR Surgical as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.